04/07 | TOP STORIES ITALIA : piace agli analisti lo shopping in Francia di Exor |  |
28/06 | Merck & Co. to Supply Keytruda Drug for Transgene, BioInvent's Clinical Study in Solid .. |  |
28/06 | Transgene and Bioinvent Announces Clinical Trial Collaboration and Supply Agreement wit.. |  |
27/06 | TRANSGENE : Presentation |  |
27/06 | Transgene SA and BioInvent International AB Announce Positive Progress for BT-001 |  |
15/06 | TRANSGENE : Virus Powered Immunotherapies against Solid Tumors |  |
06/06 | Transgene SA Presented Additional Phase I Data with TG4050 at ASCO 2022 |  |
27/05 | Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials.. |  |
25/05 | Transgene SA Approves Board and Committee Changes |  |
23/05 | Roche geht Partnerschaft mit US-Biotechfirma Kalivir Immunotherapeutics ein |  |
22/04 | TRANSGENE : Presentation |  |
31/03 | TransgeneS Board of Directors Proposes the Appointment of Dr. Alessandro Riva as .. |  |
16/03 | TRANSCRIPT : Transgene SA, 2021 Earnings Call, Mar 16, 2022 |  |
16/03 | Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2021 |  |
09/03 | Transgene to Present New Positive Preliminary Phase I Data on TG4050 |  |
08/03 | BioInvent and Transgene Announce Poster Presentation on BT-001, a Novel Antibody-encodi.. |  |
10/02 | Transgene Names Chief Business Officer |  |
10/02 | Transgene SA Appoints Steven Bloom as Vice President and Chief Business Officer |  |
20/01 | Transgene-BioInvent's Solid Tumor Drug Shows Potential Benefits in Preclinical Studies |  |
20/01 | Bioinvent International AB & Transgene Joint JITC Publication Demonstrates the Potentia.. |  |
18/01 | Transgene and PersonGen Biotherapeutics Announce Collaboration to Evaluate New Combinat.. |  |
2021 | TRANSCRIPT : Transgene SA - Special Call |  |
2021 | AstraZeneca Exercises Option for License to Oncolytic Virus Based on Transgene's Invir... |  |
2021 | AstraZeneca Licenses Oncolytic Virus in Option Exercise Under Transgene Deal |  |
2021 | Transgene Announces License Option Exercise by Astrazeneca for an Oncolytic Virus Gener.. |  |
2021 | TRANSCRIPT : Transgene SA - Special Call |  |
2021 | Transgene and NEC Corporation Announce Positive Preliminary Data from Phase I Studies o.. |  |
2021 | Transgene and BioInvent Present Preclinical Data Highlighting the Robust Anti-Tumoral A.. |  |
2021 | BIOINVENT INTERNATIONAL : and Transgene to present preclinical data on BT-001 oncolytic vi.. |  |
2021 | Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2.. |  |
2021 | Certain Ordinary Shares of Transgene SA are subject to a Lock-Up Agreement Ending on 23.. |  |
2021 | TRANSCRIPT : Transgene SA, H1 2021 Earnings Call, Sep 22, 2021 |  |
2021 | TRANSGENE : Gastrointestinal Cancer Drug Study Confirms Potential of Cancer-Killing Virus |  |
2021 | Transgene Presents Data from Phase I Clinical Trial Confirming the Potential of the Onc.. |  |
2021 | GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon... |  |
2021 | GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla... |  |
2021 | Transgene Participates in New Cancer Research Consortium |  |
2021 | Transgene Announces Update on Phase I Clinical Trial of TG4050 |  |
2021 | GLOBAL MARKETS LIVE : Facebook, Toshiba, Fedex, Nike, Microsoft... |  |
2021 | Transgene announces First Patient Enrolled in Expanded Phase II Clinical Trial of Tg400.. |  |
2021 | GLOBAL MARKETS LIVE : Netflix, Boeing, Tesla, Delta Air Lines, Blackstone Resources.... |  |
2021 | TRANSGENE : Raises $40.6 Million in Share Sale; Stock Falls 7% |  |
2021 | EN DIRECTO DESDE LOS MERCADOS : EssilorLuxottica, Tesla, Zalando, Netflix, Stellantis, Exx.. |  |
2021 | Una vigilia de armas algo letárgica |  |
2021 | EN DIRECTO DESDE LOS MERCADOS : Inditex, Banco Bilbao, Amazon, Renault, Autogrill, Clover .. |  |
2021 | Transgene Strengthens Global IP Protection for its Novel Invir.IO™ Oncolytic Viruses En.. |  |
2021 | BioInvent, Transgene Win US FDA Nod For Phase 1/2a Study of Cancer Vaccine |  |
2021 | BIOINVENT INTERNATIONAL : and Transgene receive IND approval from the U.S. FDA for BT-001,.. |  |
2021 | Bioinvent International AB and Transgene Receive IND Approval from the U.S. FDA for BT-.. |  |
2021 | GLOBAL MARKETS LIVE : Microsoft, Apple, Tesla... |  |
2021 | TRANSGENE : April 27, 2021 - Transgene reports business update and end Q1 2021 financial p.. |  |
2021 | EN DIRECTO DESDE LOS MERCADOS : Alstom, Valneva, Credit Suisse, Givaudan, Just Eat, Air Fr.. |  |
2021 | TRANSGENE : April 12, 2021 - Transgene Announces Upcoming Investor Meetings |  |
2021 | EN DIRECTO DESDE LOS MERCADOS : Michelin, Suez, Airbus, Dassault, Bénéteau, Cellectis, Cré.. |  |
2021 | TRANSGENE : April 9, 2021 - Transgene presents initial Phase I data of TG6002, highlightin.. |  |
2021 | Transgene Presents Initial Phase I Data of TG6002, Highlighting the Potential of the In.. |  |
2021 | TRANSGENE : April 7, 2021 - Availability of Preparatory Documents for the Combined General.. |  |
2021 | TRANSGENE : April 1, 2021 - Availability of Transgene's 2020 Universal Registration Docume.. |  |
2021 | Biden saca su chequera |  |
2021 | OPINIONES DE LOS ANALISTAS DEL DÍA : LVMH, Michelin, Total, IAG, Tecan, Encavis, Royal Dut.. |  |
2021 | SGS : to Support Selecta Biosciences, AskBio's Phase One Trial for Genetic Disorder Treatm.. |  |
2021 | TRANSGENE BIOTEK : in Pact to Provide Oral, Nasal Formulations for COVID-19 Vaccine |  |
2021 | TRANSCRIPT : Transgene SA, Q4 2020 Earnings Call, Mar 10, 2021 |  |
2021 | TRANSGENE : Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination W.. |  |
2021 | TRANSGENE : Significant Milestones Achieved on All Drug Candidates in 2020 and Financial V.. |  |
2021 | Transgene Sa Reports Earnings Results for the Full Year Ended December 31, 2020 |  |
2021 | Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination .. |  |
2021 | Transgene SA Develops Individualized Immunotherapy Based on Multiple Advanced Genetic E.. |  |
2021 | TRANSGENE : March 10, 2021 - Transgene expands Phase II clinical trial of therapeutic vacc.. |  |
2021 | TRANSGENE : March 10, 2021 - Significant milestones achieved on all drug candidates in 202.. |  |
2021 | TRANSGENE : to Present Its Immuno-Oncology Expertise at Upcoming Scientific Conferences |  |
2021 | TRANSGENE : March 2, 2021 - Transgene to Present its Immuno-Oncology Expertise at Upcoming.. |  |
2021 | Marzo ataca |  |
2021 | TRANSGENE : BioInvent Enroll First Patient In Oncolytic Vaccinia Virus Trial |  |
2021 | BIOINVENT INTERNATIONAL : and Transgene has enrolled first patient in Phase I/IIa trial of.. |  |